SRTop post: @SGRodriques “At Edison, we are on a mission to leverage AI to prevent or cure all diseases. Today, we are announcing a critical step: our first partnership using our AI scientist, Kosmos, to launch new biotech companies. Many of the most transformative new medicines begin life in biotech companies rather than big pharmas. We are partnering with Population Health Partners (PHP) to deploy Kosmos across their company creation pipeline. Kosmos will assist in the creation of PHP’s companies, allowing us to bring more medicines to patients. PHP has an outstanding track record of incubating successful biotech companies like @MetseraInc (acquired by @pfizer in a $10B deal), and The Medicines Company (acquired by @Novartis for $9.7B), to name just two. With PHP, we will focus on biotechs treating population-scale diseases like cardiovascular disease and obesity. If we can scale up the process of launching Metsera-style companies, we have an opportunity to transform medicine in the coming years.”